Condition

Juvenile Idiopathic Arthritis (JIA) (4)

Overall Status

Not yet recruiting (2)

Completed (1)

Recruiting (1)

Phase

phase 2 (1)

phase 4 (1)

Sponsor

Assistance Publique - Hopitaux de Paris (1)

Horizon Pharma Ireland, Ltd., Dublin Ireland (1)

National Institute of Allergy and Infectious Diseases (NIAID) (1)

University of British Columbia (1)

Intervention

active tcvns (1)

active tcvns or sham tcvns (1)

blood sample (1)

joint puncture (1)

vimovo 250/20 (1)

vimovo 375/20 (1)

vimovo 500/20 (1)

Study Documents

Intervention Type

biological (1)

device (1)

drug (1)

Funder Type

Other (2)

Industry (1)

NIH (1)

Study Type

Interventional (2)

Observational (1)

Observational [Patient Registry] (1)

juvenile idiopathic arthritis (jia)

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Juvenile Idiopathic Arthritis (JIA) Trial in Lake Success (Active tcVNS or Sham tcVNS, Active tcVNS)

Not yet recruiting

Juvenile Idiopathic Arthritis (JIA)

Active tcVNS or Sham tcVNS
Active tcVNS

Lake Success, New York

Cohen Children's Medical Center, Northwell Health

Feb 1, 2023

Angiogenic Biomarkers in Juvenile Idiopathic Arthritis

Not yet recruiting

Juvenile Idiopathic Arthritis (JIA)

Blood sample
Joint puncture

Paris, IDF, France

Rheumatology Department, Cochin Hospital

Sep 6, 2022

Juvenile Idiopathic Arthritis (JIA) Trial in Canada

Recruiting

Juvenile Idiopathic Arthritis (JIA)

Calgary, Alberta, Canada
+13 more

Oct 26, 2021

Juvenile Idiopathic Arthritis (JIA) Trial in United States (VIMOVO 250/20, VIMOVO 375/20, VIMOVO 500/20)

Completed

Has Results

Juvenile Idiopathic Arthritis (JIA)

VIMOVO 250/20
+2 more

Little Rock, Arkansas
+16 more

Sep 7, 2017